Form 8-K - Current report:
SEC Accession No. 0001213900-13-007055
Filing Date
2013-12-09
Accepted
2013-12-09 14:15:44
Documents
25
Period of Report
2013-12-05
Items
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT f8k120513_actinium.htm 8-K 27469
2 ACTINIUM PHARMACEUTICALS, INC. CORPORATE PRESENTATION. f8k120513ex99i_actinium.htm EX-99.1 15690
3 ACTINIUM PHARMACEUTICALS, INC. PRESS RELEASE ISSUED DECEMBER 5, 2013. f8k120513ex99ii_actinium.htm EX-99.2 14227
4 logo.jpg GRAPHIC 7031
5 slide1.jpg GRAPHIC 106984
6 slide2.jpg GRAPHIC 111023
7 slide3.jpg GRAPHIC 32343
8 slide4.jpg GRAPHIC 53202
9 slide5.jpg GRAPHIC 87563
10 slide6.jpg GRAPHIC 59510
11 slide7.jpg GRAPHIC 59170
12 slide8.jpg GRAPHIC 48396
13 slide9.jpg GRAPHIC 51668
14 slide10.jpg GRAPHIC 59421
15 slide11.jpg GRAPHIC 72681
16 slide12.jpg GRAPHIC 57958
17 slide13.jpg GRAPHIC 40071
18 slide14.jpg GRAPHIC 53878
19 slide15.jpg GRAPHIC 39595
20 slide16.jpg GRAPHIC 60979
21 slide17.jpg GRAPHIC 59529
22 slide18.jpg GRAPHIC 85343
23 slide19.jpg GRAPHIC 43484
24 slide20.jpg GRAPHIC 53263
25 slide21.jpg GRAPHIC 29242
  Complete submission text file 0001213900-13-007055.txt   1814140
Mailing Address 501 FIFTH AVENUE, 3RD FLOOR NEW YORK NY 10017
Business Address 501 FIFTH AVENUE, 3RD FLOOR NEW YORK NY 10017 212-300-2131
Actinium Pharmaceuticals, Inc. (Filer) CIK: 0001388320 (see all company filings)

EIN.: 880378336 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-52446 | Film No.: 131265215
SIC: 6770 Blank Checks